Breakthroughs
FDA Approves mFlusiva: The First mRNA Flu Vaccine for Adults 50 and Older
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
